Company: DAWN
Filing Date: 2025-02-25
Form Type: 10-K
Source: 0000950170-25-026654
Chunk: 275

Company: Day One Biopharmaceuticals, Inc.
Filing Date: 2025-02-25
Form: 10-K
Item: Item 1B
Chunk 275
---
 be sold, without excluding the shares that will be sold to satisfy the tax withholding obligations. The York Rule 10b5-1 Plan expires on February 18, 2026.

On December 1, 2024, William Grossman, one of our directors, entered into a pre-arranged written stock sale plan in accordance with Rule 10b5-1 (the “Grossman Rule 10b5-1 Plan” and collectively with the Bender Rule 10b5-1 Plan, Blackman Rule 10b5-1 Plan, and York Rule 10b5-1 Plan, the “Plans”) under the Exchange Act for the sale of shares of our common stock. The Grossman Rule 10b5-1 Plan was entered into during an open trading window in accordance with our policies regarding transactions in our securities and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Grossman Rule 10b5-1 Plan provides for the potential sale of shares of our common stock, including upon the vesting and exercise of stock options, so long as the market price of our common stock is higher than certain minimum threshold prices specified in the Grossman Rule 10b5-1 Plan, between March 2, 2025 and March 1, 2026. There are 30,132 aggregate number of shares of common stock available for sale under the Grossman Rule 10b5-1 Plan. The Grossman Rule 10b5-1 Plan expires on March 1, 2026.

Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections.

None.

126

PART III

Item 10. Directors, Executive Officers and Corporate Governance.

The information required by this item will be included in our Proxy Statement for the 2025 Annual Meeting of Stockholders, to be filed with the SEC within 120 days of the fiscal year ended December 31, 2024, and is incorporated herein by reference.

Item 11. Executive Compensation.

The information required by this item will be included in our Proxy Statement for the 2025 Annual Meeting of Stockholders, to be filed with the SEC within 120 days of the fiscal year ended December 31, 2024, and is incorporated herein by reference.

Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.

The information required by this item will be included in our Proxy Statement